An Open-label Study Evaluating the Long-term Efficacy, Quality of Life, and Safety of ABSORICA® (Isotretinoin) Capsules Administered Without Food in Patients With Severe Recalcitrant Nodular Acne
Phase: PHASE4
Conditions: Acne
Sponsor: Sun Pharmaceutical Industries Limited

An Open-label Study Evaluating the Long-term Efficacy, Quality of
Life, and Safety of ABSORICA® (isotretinoin) Capsules Administered
Without Food in Patients with Severe Recalcitrant Nodular Acne
NCT number: NCT02457520
Date: 19 December 2014